SCHEMBL982065

SCHEMBL982065

O=C(CN1CCNCC1)NC1CCC1

nearest known ligand 0.90

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 9/20 0.90
CHRM5 P08912 4/20 0.90
CHRM3 P20309 3/20 0.90
CA12 O43570 2/20 0.55
CA1 P00915 2/20 0.55
CA2 P00918 2/20 0.55
CA9 Q16790 2/20 0.55
ALDH1A1 P00352 1/20 0.51
MAPK1 P28482 1/20 0.51
CHRM1 P11229 2/20 0.49
CHRM2 P08172 1/20 0.49
CHRM4 P08173 1/20 0.49
DRD4 P21917 1/20 0.48
DRD3 P35462 1/20 0.48
KMT2A Q03164 1/20 0.48
LMNA P02545 1/20 0.47
TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1073695 0.95 SIGMAR1 (0.82) SIGMAR1CHRM5CHRM3CA12CA1
Esaprazole SCHEMBL931007 0.95 SIGMAR1 (1.00) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL1901358 0.93 SIGMAR1 (0.84) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL981182 0.87 SIGMAR1 (0.74) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL11627783 0.85 SIGMAR1 (0.72) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL13640016 0.85 SIGMAR1 (0.72) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL28391152 0.85 SIGMAR1 (0.72) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL12814299 0.84 SIGMAR1 (0.71) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL975809 0.83 SIGMAR1 (0.68) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL976514 0.83 SIGMAR1 (0.68) SIGMAR1CHRM5CHRM3CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011000945-A9 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-04-07 WO claimed
WO-2011000945-A9 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-04-07 WO disclosed
WO-2011000945-A2 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-01-06 WO disclosed